Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Nature
2018 Feb 01;5547690:112-117. doi: 10.1038/nature25449.
Show Gene links
Show Anatomy links
Tissue-selective effects of nucleolar stress and rDNA damage in developmental disorders.
Calo E
,
Gu B
,
Bowen ME
,
Aryan F
,
Zalc A
,
Liang J
,
Flynn RA
,
Swigut T
,
Chang HY
,
Attardi LD
,
Wysocka J
.
???displayArticle.abstract???
Many craniofacial disorders are caused by heterozygous mutations in general regulators of housekeeping cellular functions such as transcription or ribosome biogenesis. Although it is understood that many of these malformations are a consequence of defects in cranial neural crest cells, a cell type that gives rise to most of the facial structures during embryogenesis, the mechanism underlying cell-type selectivity of these defects remains largely unknown. By exploring molecular functions of DDX21, a DEAD-box RNA helicase involved in control of both RNA polymerase (Pol) I- and II-dependent transcriptional arms of ribosome biogenesis, we uncovered a previously unappreciated mechanism linking nucleolar dysfunction, ribosomal DNA (rDNA) damage, and craniofacial malformations. Here we demonstrate that genetic perturbations associated with Treacher Collins syndrome, a craniofacial disorder caused by heterozygous mutations in components of the Pol I transcriptional machinery or its cofactor TCOF1 (ref. 1), lead to relocalization of DDX21 from the nucleolus to the nucleoplasm, its loss from the chromatin targets, as well as inhibition of rRNA processing and downregulation of ribosomal protein gene transcription. These effects are cell-type-selective, cell-autonomous, and involve activation of p53 tumour-suppressor protein. We further show that cranial neural crest cells are sensitized to p53-mediated apoptosis, but blocking DDX21 loss from the nucleolus and chromatin rescues both the susceptibility to apoptosis and the craniofacial phenotypes associated with Treacher Collins syndrome. This mechanism is not restricted to cranial neural crest cells, as blood formation is also hypersensitive to loss of DDX21 functions. Accordingly, ribosomal gene perturbations associated with Diamond-Blackfan anaemia disrupt DDX21 localization. At the molecular level, we demonstrate that impaired rRNA synthesis elicits a DNA damage response, and that rDNA damage results in tissue-selective and dosage-dependent effects on craniofacial development. Taken together, our findings illustrate how disruption in general regulators that compromise nucleolar homeostasis can result in tissue-selective malformations.
Bajpai,
CHD7 cooperates with PBAF to control multipotent neural crest formation.
2010, Pubmed,
Xenbase
Bajpai,
CHD7 cooperates with PBAF to control multipotent neural crest formation.
2010,
Pubmed
,
Xenbase
Berdasco,
Genetic syndromes caused by mutations in epigenetic genes.
2013,
Pubmed
Berkson,
Pilot screening programme for small molecule activators of p53.
2005,
Pubmed
Bronner,
Development and evolution of the neural crest: an overview.
2012,
Pubmed
,
Xenbase
Buecker,
Reorganization of enhancer patterns in transition from naive to primed pluripotency.
2014,
Pubmed
Burridge,
Chemically defined generation of human cardiomyocytes.
2014,
Pubmed
Calo,
RNA helicase DDX21 coordinates transcription and ribosomal RNA processing.
2015,
Pubmed
Carey,
Dignam and Roeder nuclear extract preparation.
2009,
Pubmed
Chailleux,
Quantifying DNA double-strand breaks induced by site-specific endonucleases in living cells by ligation-mediated purification.
2014,
Pubmed
Danielian,
Modification of gene activity in mouse embryos in utero by a tamoxifen-inducible form of Cre recombinase.
1998,
Pubmed
Dixon,
Tcof1/Treacle is required for neural crest cell formation and proliferation deficiencies that cause craniofacial abnormalities.
2006,
Pubmed
Dixon,
Increased levels of apoptosis in the prefusion neural folds underlie the craniofacial disorder, Treacher Collins syndrome.
2000,
Pubmed
Dolma,
Identification of genotype-selective antitumor agents using synthetic lethal chemical screening in engineered human tumor cells.
2003,
Pubmed
Flick,
DNA binding and cleavage by the nuclear intron-encoded homing endonuclease I-PpoI.
1998,
Pubmed
Flynn,
Dissecting noncoding and pathogen RNA-protein interactomes.
2015,
Pubmed
Gonzales,
The Treacher Collins syndrome (TCOF1) gene product is involved in pre-rRNA methylation.
2005,
Pubmed
,
Xenbase
Grier,
Conditional allele of mdm2 which encodes a p53 inhibitor.
2002,
Pubmed
Hu,
Effects of cellular origin on differentiation of human induced pluripotent stem cell-derived endothelial cells.
2016,
Pubmed
Jones,
Prevention of the neurocristopathy Treacher Collins syndrome through inhibition of p53 function.
2008,
Pubmed
Kadakia,
Treacher Collins Syndrome: the genetics of a craniofacial disease.
2014,
Pubmed
Lau,
Pathogenesis of POLR1C-dependent Type 3 Treacher Collins Syndrome revealed by a zebrafish model.
2016,
Pubmed
Muscarella,
Characterization of I-Ppo, an intron-encoded endonuclease that mediates homing of a group I intron in the ribosomal DNA of Physarum polycephalum.
1990,
Pubmed
Narla,
Ribosomopathies: human disorders of ribosome dysfunction.
2010,
Pubmed
Noack Watt,
The Roles of RNA Polymerase I and III Subunits Polr1c and Polr1d in Craniofacial Development and in Zebrafish Models of Treacher Collins Syndrome.
2016,
Pubmed
Prescott,
Enhancer divergence and cis-regulatory evolution in the human and chimp neural crest.
2015,
Pubmed
Rinon,
p53 coordinates cranial neural crest cell growth and epithelial-mesenchymal transition/delamination processes.
2011,
Pubmed
Sakai,
Prevention of Treacher Collins syndrome craniofacial anomalies in mouse models via maternal antioxidant supplementation.
2016,
Pubmed
Sloan,
The association of late-acting snoRNPs with human pre-ribosomal complexes requires the RNA helicase DDX21.
2015,
Pubmed
Song,
SIRT7 and the DEAD-box helicase DDX21 cooperate to resolve genomic R loops and safeguard genome stability.
2017,
Pubmed
Trainor,
Craniofacial birth defects: The role of neural crest cells in the etiology and pathogenesis of Treacher Collins syndrome and the potential for prevention.
2010,
Pubmed
Truett,
Preparation of PCR-quality mouse genomic DNA with hot sodium hydroxide and tris (HotSHOT).
2000,
Pubmed
Valdez,
RNA-unwinding and RNA-folding activities of RNA helicase II/Gu--two activities in separate domains of the same protein.
1997,
Pubmed
Van Nostrand,
Inappropriate p53 activation during development induces features of CHARGE syndrome.
2014,
Pubmed
Weiner,
Fishing the molecular bases of Treacher Collins syndrome.
2012,
Pubmed
Yelick,
Ribosomopathies: Global process, tissue specific defects.
2015,
Pubmed
Zarnegar,
irCLIP platform for efficient characterization of protein-RNA interactions.
2016,
Pubmed
Zhang,
Assessment of hematopoietic failure due to Rpl11 deficiency in a zebrafish model of Diamond-Blackfan anemia by deep sequencing.
2013,
Pubmed